ES2902850T3 - Composición tópica de ketoprofeno - Google Patents

Composición tópica de ketoprofeno Download PDF

Info

Publication number
ES2902850T3
ES2902850T3 ES13842525T ES13842525T ES2902850T3 ES 2902850 T3 ES2902850 T3 ES 2902850T3 ES 13842525 T ES13842525 T ES 13842525T ES 13842525 T ES13842525 T ES 13842525T ES 2902850 T3 ES2902850 T3 ES 2902850T3
Authority
ES
Spain
Prior art keywords
percent
ketoprofen
carbopol
composition
topical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13842525T
Other languages
English (en)
Spanish (es)
Inventor
Servet Buyuktimkin
Nadir Buyuktimkin
James L Yeager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Achelios Therapeutics Inc
Original Assignee
Achelios Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achelios Therapeutics Inc filed Critical Achelios Therapeutics Inc
Application granted granted Critical
Publication of ES2902850T3 publication Critical patent/ES2902850T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES13842525T 2012-09-27 2013-09-24 Composición tópica de ketoprofeno Active ES2902850T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261706163P 2012-09-27 2012-09-27
US13/826,706 US8822537B2 (en) 2012-09-27 2013-03-14 Topical ketoprofen composition
PCT/US2013/061403 WO2014052313A1 (en) 2012-09-27 2013-09-24 Topical ketoprofen composition

Publications (1)

Publication Number Publication Date
ES2902850T3 true ES2902850T3 (es) 2022-03-30

Family

ID=50339476

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13842525T Active ES2902850T3 (es) 2012-09-27 2013-09-24 Composición tópica de ketoprofeno

Country Status (13)

Country Link
US (1) US8822537B2 (https=)
EP (1) EP2900231B1 (https=)
JP (1) JP6238991B2 (https=)
KR (1) KR102184245B1 (https=)
AU (1) AU2013323766B2 (https=)
BR (1) BR112015006790B1 (https=)
CA (1) CA2885619C (https=)
ES (1) ES2902850T3 (https=)
IL (1) IL237810B (https=)
MX (1) MX373916B (https=)
NZ (1) NZ706108A (https=)
RU (1) RU2652345C2 (https=)
WO (1) WO2014052313A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6205133B2 (ja) 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
EP3226972A4 (en) * 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
AU2016301282B2 (en) 2015-08-03 2022-03-17 Children's Medical Center Corporation Charged ion channel blockers and methods for use
WO2017106714A1 (en) * 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
KR20190003535A (ko) * 2016-03-31 2019-01-09 스마테크 토피칼, 인코포레이티드 전달 시스템
KR20200094161A (ko) * 2017-11-30 2020-08-06 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 케토프로펜, 이의 염 및 거울상 이성질체의 안정한 액체 조성물
BR112021017809A2 (pt) 2019-03-11 2021-11-23 Nocion Therapeutics Inc Bloqueadores de canais iônicos substituídos por éster e métodos para uso
AU2020234961C1 (en) 2019-03-11 2025-08-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
CA3139559A1 (en) 2019-05-09 2020-11-12 Apkarian Technologies Llc Methods and compositions for treating pain
WO2021091586A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US20220378729A1 (en) * 2019-11-06 2022-12-01 Smartech Topical, Inc. Topical formulations of cyclooxygenase inhibitors and their use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
US5863527A (en) * 1996-09-04 1999-01-26 The Proctor & Gamble Company Personal care compositions
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
CN1536983A (zh) * 2001-05-30 2004-10-13 宝洁公司 包括取代的化妆品键合剂的局部组合物
DE10141258B4 (de) * 2001-08-23 2004-09-23 Beiersdorf Ag Kosmetische und dermatologische Zubereitung und ihre Verwendung
US7235230B2 (en) * 2001-10-24 2007-06-26 Clariant Finance (Bvi) Limited Leave-on compositions for personal care
ITFI20030070A1 (it) * 2003-03-18 2004-09-19 Berlin Chemie Ag Formulazioni topiche stabilizzate contenenti ketoprofene
EP1488787A1 (en) * 2003-06-20 2004-12-22 Berlin-Chemie Ag Topical stabilized formulations containing ketoprofen
DK1670433T3 (da) * 2003-10-10 2012-03-12 Ferring Bv Transdermal farmaceutisk formulering til mindskelse af hudrester
US7928144B2 (en) * 2004-06-15 2011-04-19 Hisamitsu Pharmaceutical Co., Inc. Antiinflammatory and analgesic preparation for external use
ES2370511T3 (es) * 2005-02-25 2011-12-19 Hisamitsu Pharmaceutical Co., Inc. Preparado transdérmico para uso externo que contiene un agente analgésico/antiinflamatorio no esteroideo.
CA2619073A1 (en) * 2005-09-15 2007-03-22 Biomas Ltd. Use of tellurium compounds for protection from ultra-violet radiation
WO2007118605A1 (en) * 2006-04-18 2007-10-25 Dsm Ip Assets B.V. Cosmetic compositions comprising salicylic acid and ascorbic acid
US8080562B2 (en) * 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
US8409600B2 (en) * 2009-01-23 2013-04-02 J&E Solutions, Llc Methods for prevention and/or treatment of capsular contracture
WO2011075688A1 (en) * 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions

Also Published As

Publication number Publication date
EP2900231A1 (en) 2015-08-05
JP2015531374A (ja) 2015-11-02
IL237810B (en) 2018-06-28
BR112015006790A2 (pt) 2017-07-04
RU2015115723A (ru) 2016-11-20
JP6238991B2 (ja) 2017-11-29
KR102184245B1 (ko) 2020-11-30
WO2014052313A1 (en) 2014-04-03
NZ706108A (en) 2018-03-23
HK1212898A1 (en) 2016-06-24
EP2900231B1 (en) 2021-11-03
KR20150074009A (ko) 2015-07-01
BR112015006790B1 (pt) 2022-05-31
EP2900231A4 (en) 2016-03-02
US8822537B2 (en) 2014-09-02
CA2885619A1 (en) 2014-04-03
MX373916B (es) 2020-07-10
US20140088195A1 (en) 2014-03-27
CA2885619C (en) 2020-09-08
MX2015004006A (es) 2015-10-29
AU2013323766A1 (en) 2015-04-09
RU2652345C2 (ru) 2018-04-25
AU2013323766B2 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
ES2902850T3 (es) Composición tópica de ketoprofeno
JP2015531374A5 (https=)
US10117829B2 (en) Diclofenac formulations
US5807568A (en) Enhanced delivery of topical compositions containing flurbiprofen
ES2318233T3 (es) Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona.
AU2019203449B2 (en) Topical diclofenac sodium compositions
JP5052558B2 (ja) ゲル軟膏
US20060241175A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
WO2005123136A1 (ja) 消炎鎮痛外用剤
JP4195178B2 (ja) 消炎鎮痛外用剤
JP2024163305A (ja) ロキソプロフェン及び可溶化剤を含有する皮膚外用剤
US10028927B2 (en) Topical pharmaceutical formulation
US20160310508A1 (en) Testosterone gel compositions and related methods
JP2026501200A (ja) 局所用医薬組成物及びその使用
KR101894891B1 (ko) 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형
HK1212898B (en) Topical ketoprofen composition
ES2758198T3 (es) Composiciones analgésicas pulverizables
US20190216721A1 (en) Topical pharmaceutical formulation